Research on HTA Supporting Innovative High-Value Medical Consumables Medical Insurance Access
Health technology assessment(HTA)can scientifically identify the clinical value of innovative high-value consumables and provide an evidence-based basis for health insurance access decision-making.HTA in the field of medical consumables starts late in China,and there are no mature guidelines or application specifications.Based on the analysis at home and abroad,it is suggested that we can explore the classification of assessment,and carry out HTA for innovative high-value consumables with high degree of innovation,high therapeutic cost,and significant impact on the fund.At the same time,we should pay attention to the special characteristics of consumables,differentiate the design of the key techniques of HTA,choose more blank references,refer to real-world data,use cost-consequence analysis(CCA),consider parameters such as training/maintenance costs,and consider the effects of learning curve.When making decisions on medical insurance access,HTA should be used to assist decision-making,and in a few cases where the assessment results are sufficiently sound and the market is stable,the results of the HTA can be considered as the main basis for decision-making.
NETL
NSTL
万方数据
